Korro Bio (KRRO) Current Deferred Revenue (2019 - 2026)
Korro Bio (KRRO) posted Current Deferred Revenue of $179000.0 for Q1 2026, down 94.63% on a QoQ basis from $3.3 million in Q3 2025, and down 93.61% year-over-year from $2.8 million in Q1 2025.
Korro Bio (KRRO) Current Deferred Revenue (2019 - 2026) Analysis & Trends
Korro Bio's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $179000.0 for Q1 2026.
- Quarterly Current Deferred Revenue fell 93.61% year-over-year to $179000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $179000.0 (down 93.61% YoY) and the FY2024 annual result came in at $3.5 million, changed N/A from the prior year.
- Current Deferred Revenue was $179000.0 for Q1 2026 at Korro Bio, down from $3.3 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $3.9 million in Q2 2025 and bottomed at $179000.0 in Q1 2026.
- A 3-year average of $2.7 million and a median of $3.1 million in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2025 — Current Deferred Revenue jumped 51.39% — and 2026, when it sank 93.61%.
- Korro Bio's Current Deferred Revenue stood at $3.5 million in 2024, then fell by 5.15% to $3.3 million in 2025, then plunged by 94.63% to $179000.0 in 2026.
- Business Quant data shows KRRO's Current Deferred Revenue at $179000.0 in Q1 2026, $3.3 million in Q3 2025, and $3.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179,000.00 |
| Sep 30, 2025 | 3.33 Mn |
| Jun 30, 2025 | 3.93 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Mar 31, 2021 | 9.42 Mn |
| Dec 31, 2020 | 14.07 Mn |
| Sep 30, 2020 | 24.02 Mn |
| Jun 30, 2020 | 35.27 Mn |
| Mar 31, 2020 | 38.67 Mn |
| Dec 31, 2019 | 48.15 Mn |
| Sep 30, 2019 | 49.36 Mn |